Tag: COVID-19

Long-term immune response to COVID-19 in children, adults

Editor's Note This Italian study describes the long-term features of the immune response to COVID-19 for different ages after mild infection. In this cohort of 252 family clusters with COVID-19, the immune response persisted until 12 months after infection in all age groups, with significantly higher antibody peaks for younger…

Read More

By: Judy Mathias
July 13, 2022
Share

CDC: COVID-19 reverses progress in fight against superbugs

Editor's Note The COVID-19 pandemic has caused a surge in antimicrobial resistance in US hospitals, reversing years of progress, according to a new analysis released July 12 by the Centers for Disease Control and Prevention (CDC). During the first year of the pandemic, antimicrobial-resistant infections and deaths increased in hospitals…

Read More

By: Judy Mathias
July 13, 2022
Share

Researchers develop model to explain Long COVID

Editor's Note In this study, researchers in New Zealand identify how post-viral fatigue syndromes, including Long COVID, become life-changing diseases and why patients have frequent relapses. Viral infections commonly result in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, which causes brain-centered symptoms of neuroinflammation, brain fog, lack of refreshing sleep, and poor response…

Read More

By: Judy Mathias
July 13, 2022
Share

UH Cleveland Medical Center awarded AHA Quest for Quality Prize

Editor's Note The American Hospital Association (AHA) will present this year’s Quest for Quality Prize to University Hospitals Cleveland Medical Center (UH) on July 18 at the AHA Leadership Summit in San Diego. UH is receiving the award because of its data-driven quality and safety improvements and innovative strategies to…

Read More

By: Judy Mathias
July 13, 2022
Share

Effectiveness of decontaminating PPE with methylene blue

Editor's Note This study led by researchers at the University of Washington, Seattle, finds that methylene blue with light (MBL) photochemical treatment can be used to decontaminate personal protective equipment (PPE) contaminated with COVID-19. MBL robustly and consistently inactivated three coronaviruses, including COVID-19, with 99.8% to >99.9% virus inactivation across…

Read More

By: Judy Mathias
July 12, 2022
Share

Wastewater provides early detection of COVID-19 variant transmission

Editor's Note Scientists at UC San Diego and Scripps Research have developed tools to analyze wastewater that have proven effective in identifying emerging COVID-19 variants and predicting surges. COVID-19 patients shed the virus in their stool, whether they have symptoms or not. In the summer of 2020 the scientists began…

Read More

By: Judy Mathias
July 12, 2022
Share

First cases of newest Omicron subvariant found in US

Editor's Note Three cases of the newest Omicron subvariant BA.2.75 have been detected on the West Coast, two in California and one in Washington, the July 11 Becker’s Hospital Review reports. The subvariant is also in India and 10 other countries. The subvariant has a large number of mutations that…

Read More

By: Judy Mathias
July 12, 2022
Share

Cancer screening decreased worldwide during COVID-19

Editor's Note This systematic review and meta-analysis from Stony Brook Cancer Center, Stony Brook University, New York City, and the University of Bologna, Bologna, Italy, finds that COVID-19 pandemic measures were associated with widely reduced cancer screening services. Between January and October 2020, there was an overall decrease of: -46.7%…

Read More

By: Judy Mathias
July 11, 2022
Share

New study: Disposable gowns may expose clinicians to infection

Editor's Note After this October 2020 peer-reviewed study, titled “Disposable versus reusable medical gowns: A performance comparison,” found that “isolation gowns commonly worn in medical units or intensive care units ripped too easily and allowed about four to 14 times the expected amount of liquid to seep through when sprayed…

Read More

By: Tarsilla Moura
July 8, 2022
Share

FDA allows for pharmacists to prescribe Paxlovid to treat COVID-19

Editor's Note The US Food and Drug Administration (FDA) announced on July 6 that it would alter its emergency use authorization for the Paxlovid pill—Pfizer’s oral antiviral pill used by some to treat COVID-19—to allow pharmacists to prescribe the treatment to recently affected individuals directly. According to Fierce Pharma July…

Read More

By: Tarsilla Moura
July 8, 2022
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat